These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15013947)

  • 1. HEP DART 2003: Frontiers in drug development for viral hepatitis.
    Raney AK; Hamatake RK; Hong Z
    Expert Opin Investig Drugs; 2004 Mar; 13(3):289-93. PubMed ID: 15013947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral hepatitis. From prevention to antivirals.
    Jonas MM
    Clin Liver Dis; 2000 Nov; 4(4):849-77. PubMed ID: 11232361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 5. [The ABC of viral hepatitis].
    Van Bambeke F
    J Pharm Belg; 2008 Mar; 63(1):15-20. PubMed ID: 18479077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis and treatment of viral hepatitis.
    Damjanovic V; Brumfitt W
    J Antimicrob Chemother; 1980 Jan; 6(1):11-32. PubMed ID: 6766920
    [No Abstract]   [Full Text] [Related]  

  • 7. Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.
    Boettler T; Moradpour D; Thimme R; Zoulim F
    J Hepatol; 2014 Sep; 61(3):696-705. PubMed ID: 24845610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC releases 2002 guidelines for treating STDs: Part II. Human papillomavirus and hepatitis.
    Ressel GW;
    Am Fam Physician; 2002 Nov; 66(10):1996, 1999. PubMed ID: 12469970
    [No Abstract]   [Full Text] [Related]  

  • 10. HEP DART 2005 -- frontiers in drug development for viral hepatitis.
    Feitelson MA
    IDrugs; 2006 Mar; 9(3):165-7. PubMed ID: 16523376
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.
    Yotsuyanagi H; Koike K
    J Gastroenterol; 2007 May; 42(5):329-35. PubMed ID: 17530355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C Viruses and Biologics.
    Grewal P; Sanghera R
    Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacoeconomic appraisal of therapies for hepatitis B and C.
    Younossi ZM; Temple ME; Shermock KM
    Expert Opin Pharmacother; 2001 Feb; 2(2):205-11. PubMed ID: 11336580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and strategies for viral hepatitis control in Korea.
    Sinn DH; Cho EJ; Kim JH; Kim DY; Kim YJ; Choi MS
    Clin Mol Hepatol; 2017 Sep; 23(3):189-195. PubMed ID: 28942620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral hepatitis: impressive advances but still a long way to eradication of the disease.
    Marcellin P; Asselah T
    Liver Int; 2014 Feb; 34 Suppl 1():1-3. PubMed ID: 24373070
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses.
    Tanikawa K
    Curr Pharm Des; 2006; 12(11):1371-7. PubMed ID: 16611121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.
    Mascolini M; Mellors JW; Richman DD; Boucher CA; Larder BA
    Antivir Ther; 2011; 16(2):263-86. PubMed ID: 21447877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.